Next-Generation Therapeutics for IBD

Ian Lawrance, J. Mill, Prevention of cancer in IBD - a balancing act. Minerva gastroenterologica e dietologica. ,vol. 59, pp. 261- 272 ,(2013)

William J Sandborn, Subrata Ghosh, Julian Panes, Ivana Vranic, Wenjin Wang, Wojciech Niezychowski, Severine ARA Vermeire, Olivier Dewit, Harald Peeters, Jiri Stehlik, Tomas Vanasek, David Laharie, Jean Frederic Colombel, Marc-André Bigard, Marta Varga, Margit Zeher, Janos Novak, Bela Hunyady, Agnes Salamon, Istvan Racz, Paolo Gionchetti, Anna Kohn, Cosimo Prantera, PCF Stokkers, Maria Slomka, Leszek Paradowski, Tomasz Arlukowicz, Ladislav Kuzela, Boris Baricky, Tibor Hlavaty, Maria Isabel Vera, Jordi Guardiola, Christopher Probert, Jonathan Lionel Shaffer, Mark Fleisher, Ronald Edward Pruitt, John Sawyer Goff, John Weber, Raymond Lloyd Bell, Andrew Harrison Zwick, Alexandra Gutierrez, Robert H Levine, Stephen Brett Hanauer, Lori Ann Lavelle, Ravindranath K Kottoor, Gerald Wayne Dryden Jr, Robert Hardi, David Vaughn Glorioso, Prabhakar Swaroop, Scott D Lee, Teressa Joan Patrick, Sheldon Scheinert, Charles A Sninsky, Seymour Katz, Mark D Noar, Michael Marion Gaspari, Glenn L Gordon, Thomas A Dalton, Douglas Edward Homoky, William Ransom Kilgore III, Joel A Levien, Herbert R Schneider, Suleman Abdul Moola, Frederik Cornelius Kruger, John P Wright, Nazimuddin Aboo, None, A Phase 2 Study of Tofacitinib, an Oral Janus Kinase Inhibitor, in Patients With Crohn’s Disease Clinical Gastroenterology and Hepatology. ,vol. 12, pp. 1485- 1493 ,(2014) , 10.1016/J.CGH.2014.01.029

Stanley Cohen, Sebastião C. Radominski, Juan J. Gomez‐Reino, Lisy Wang, Sriram Krishnaswami, Susan P. Wood, Koshika Soma, Chudi I. Nduaka, Kenneth Kwok, Hernan Valdez, Birgitta Benda, Richard Riese, Analysis of infections and all-cause mortality in phase II, phase III, and long-term extension studies of tofacitinib in patients with rheumatoid arthritis. Arthritis & Rheumatism. ,vol. 66, pp. 2924- 2937 ,(2014) , 10.1002/ART.38779

William J. Sandborn, Simon Travis, Luigi Moro, Richard Jones, Theres Gautille, Robert Bagin, Michael Huang, Phil Yeung, E. David Ballard, Once-Daily Budesonide MMX® Extended-Release Tablets Induce Remission in Patients With Mild to Moderate Ulcerative Colitis: Results From the CORE I Study Gastroenterology. ,vol. 143, pp. 1218- 1226 ,(2012) , 10.1053/J.GASTRO.2012.08.003

Lalitha Vijayakrishnan, R. Venkataramanan, Palak Gulati, Treating inflammation with the Janus Kinase inhibitor CP-690,550 Trends in Pharmacological Sciences. ,vol. 32, pp. 25- 34 ,(2011) , 10.1016/J.TIPS.2010.10.004

William J Sandborn, Brian G Feagan, Colleen Marano, Hongyan Zhang, Richard Strauss, Jewel Johanns, Omoniyi J Adedokun, Cynthia Guzzo, Jean-Frederic Colombel, Walter Reinisch, Peter R Gibson, Judith Collins, Gunnar Järnerot, Toshifumi Hibi, Paul Rutgeerts, PURSUIT-SC Study Group, Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis. Gastroenterology. ,vol. 146, pp. 85- 95 ,(2014) , 10.1053/J.GASTRO.2013.05.048

William J. Sandborn, Subrata Ghosh, Julian Panes, Ivana Vranic, Chinyu Su, Samantha Rousell, Wojciech Niezychowski, Tofacitinib, an oral Janus kinase inhibitor, in active ulcerative colitis. The New England Journal of Medicine. ,vol. 367, pp. 616- 624 ,(2012) , 10.1056/NEJMOA1112168

Jean–Frédéric Colombel, William J. Sandborn, Paul Rutgeerts, Robert Enns, Stephen B. Hanauer, Remo Panaccione, Stefan Schreiber, Dan Byczkowski, Ju Li, Jeffrey D. Kent, Paul F. Pollack, Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial. Gastroenterology. ,vol. 132, pp. 52- 65 ,(2007) , 10.1053/J.GASTRO.2006.11.041

Lisa M Lundquist, Efficacy and safety of tofacitinib for treatment of rheumatoid arthritis. World journal of orthopedics. ,vol. 5, pp. 504- 511 ,(2014) , 10.5312/WJO.V5.I4.504

A.J. Walsh, M. Weltman, D. Burger, S. Vivekanandarajah, S. Connor, M. Howlett, G. Radford-Smith, W. Selby, A.S. Veillard, M.C. Grimm, S.P.L. Travis, I.C. Lawrance, Implementing guidelines on the prevention of opportunistic infections in inflammatory bowel disease Journal of Crohn's and Colitis. ,vol. 7, ,(2013) , 10.1016/J.CROHNS.2013.02.019